Access to opioid analgesics in Poland - a brief analysis of the current regulation of opioids following recent legislative changes

Iga Pawlowska, Aleksandra Modlinska, Leszek Pawlowski*, Natalia Krzyzaniak, Ivan Kocic, Monika Lichodziejewska-Niemierko

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The use of opioid analgesics commonly results in tolerance, dependence and addiction, requiring their classification as controlled substances. This, in turn, creates access barriers and increases the complexity of treating severe pain. The aim of this study was to provide an insight into the current legal impediments that limit opioid access in Poland, subsequent to recent changes in Polish legislation. Two methods were utilized. First, Polish legal acts relating to controlled medicines were analyzed. Following this, a short e-mail survey was distributed to pharmacy inspectors to identify the percent of community pharmacies that dispense opioid analgesics. There are a range of stringent requirements that control the use of opioids, and must be adhered to by medical staff. In Poland, every registered physician is authorized to prescribe opioids, and 90% of pharmacies must dispense these drugs. With regards to prescribing, the single or daily doses of opioids are not limited, and the amount of controlled medicine prescribed on one prescription is limited to 90 days use, in accordance with the dosage regimen. An opioid-based prescription is valid for 30 days. Other restrictions to opioid access are related to the storage, dispensing, usage and availability of controlled medicines. The barriers identified may limit access to opioids on one hand, but on the other, the changes in Polish law have alleviated the requirements for prescribing these medicines. Therefore, it is important to achieve an acceptable balance between the restrictions imposed on opioids usage and their adequate clinical application.

Original languageEnglish
Pages (from-to)545-548
Number of pages4
JournalActa Poloniae Pharmaceutica - Drug Research
Volume75
Issue number2
Publication statusPublished - 6 Apr 2018
Externally publishedYes

Fingerprint

Poland
Opioid Analgesics
Pharmacies
Prescriptions
Controlled Substances
Medical Staff
Postal Service
Legislation
Medicine
Physicians
Pain

Cite this

Pawlowska, Iga ; Modlinska, Aleksandra ; Pawlowski, Leszek ; Krzyzaniak, Natalia ; Kocic, Ivan ; Lichodziejewska-Niemierko, Monika. / Access to opioid analgesics in Poland - a brief analysis of the current regulation of opioids following recent legislative changes. In: Acta Poloniae Pharmaceutica - Drug Research. 2018 ; Vol. 75, No. 2. pp. 545-548.
@article{b0e9c681164041ceb1e7c501b3ff5539,
title = "Access to opioid analgesics in Poland - a brief analysis of the current regulation of opioids following recent legislative changes",
abstract = "The use of opioid analgesics commonly results in tolerance, dependence and addiction, requiring their classification as controlled substances. This, in turn, creates access barriers and increases the complexity of treating severe pain. The aim of this study was to provide an insight into the current legal impediments that limit opioid access in Poland, subsequent to recent changes in Polish legislation. Two methods were utilized. First, Polish legal acts relating to controlled medicines were analyzed. Following this, a short e-mail survey was distributed to pharmacy inspectors to identify the percent of community pharmacies that dispense opioid analgesics. There are a range of stringent requirements that control the use of opioids, and must be adhered to by medical staff. In Poland, every registered physician is authorized to prescribe opioids, and 90{\%} of pharmacies must dispense these drugs. With regards to prescribing, the single or daily doses of opioids are not limited, and the amount of controlled medicine prescribed on one prescription is limited to 90 days use, in accordance with the dosage regimen. An opioid-based prescription is valid for 30 days. Other restrictions to opioid access are related to the storage, dispensing, usage and availability of controlled medicines. The barriers identified may limit access to opioids on one hand, but on the other, the changes in Polish law have alleviated the requirements for prescribing these medicines. Therefore, it is important to achieve an acceptable balance between the restrictions imposed on opioids usage and their adequate clinical application.",
author = "Iga Pawlowska and Aleksandra Modlinska and Leszek Pawlowski and Natalia Krzyzaniak and Ivan Kocic and Monika Lichodziejewska-Niemierko",
year = "2018",
month = "4",
day = "6",
language = "English",
volume = "75",
pages = "545--548",
journal = "Acta Poloniae Pharmaceutica",
issn = "0001-6837",
publisher = "Polish Pharmaceutical Society",
number = "2",

}

Access to opioid analgesics in Poland - a brief analysis of the current regulation of opioids following recent legislative changes. / Pawlowska, Iga; Modlinska, Aleksandra; Pawlowski, Leszek; Krzyzaniak, Natalia; Kocic, Ivan; Lichodziejewska-Niemierko, Monika.

In: Acta Poloniae Pharmaceutica - Drug Research, Vol. 75, No. 2, 06.04.2018, p. 545-548.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Access to opioid analgesics in Poland - a brief analysis of the current regulation of opioids following recent legislative changes

AU - Pawlowska, Iga

AU - Modlinska, Aleksandra

AU - Pawlowski, Leszek

AU - Krzyzaniak, Natalia

AU - Kocic, Ivan

AU - Lichodziejewska-Niemierko, Monika

PY - 2018/4/6

Y1 - 2018/4/6

N2 - The use of opioid analgesics commonly results in tolerance, dependence and addiction, requiring their classification as controlled substances. This, in turn, creates access barriers and increases the complexity of treating severe pain. The aim of this study was to provide an insight into the current legal impediments that limit opioid access in Poland, subsequent to recent changes in Polish legislation. Two methods were utilized. First, Polish legal acts relating to controlled medicines were analyzed. Following this, a short e-mail survey was distributed to pharmacy inspectors to identify the percent of community pharmacies that dispense opioid analgesics. There are a range of stringent requirements that control the use of opioids, and must be adhered to by medical staff. In Poland, every registered physician is authorized to prescribe opioids, and 90% of pharmacies must dispense these drugs. With regards to prescribing, the single or daily doses of opioids are not limited, and the amount of controlled medicine prescribed on one prescription is limited to 90 days use, in accordance with the dosage regimen. An opioid-based prescription is valid for 30 days. Other restrictions to opioid access are related to the storage, dispensing, usage and availability of controlled medicines. The barriers identified may limit access to opioids on one hand, but on the other, the changes in Polish law have alleviated the requirements for prescribing these medicines. Therefore, it is important to achieve an acceptable balance between the restrictions imposed on opioids usage and their adequate clinical application.

AB - The use of opioid analgesics commonly results in tolerance, dependence and addiction, requiring their classification as controlled substances. This, in turn, creates access barriers and increases the complexity of treating severe pain. The aim of this study was to provide an insight into the current legal impediments that limit opioid access in Poland, subsequent to recent changes in Polish legislation. Two methods were utilized. First, Polish legal acts relating to controlled medicines were analyzed. Following this, a short e-mail survey was distributed to pharmacy inspectors to identify the percent of community pharmacies that dispense opioid analgesics. There are a range of stringent requirements that control the use of opioids, and must be adhered to by medical staff. In Poland, every registered physician is authorized to prescribe opioids, and 90% of pharmacies must dispense these drugs. With regards to prescribing, the single or daily doses of opioids are not limited, and the amount of controlled medicine prescribed on one prescription is limited to 90 days use, in accordance with the dosage regimen. An opioid-based prescription is valid for 30 days. Other restrictions to opioid access are related to the storage, dispensing, usage and availability of controlled medicines. The barriers identified may limit access to opioids on one hand, but on the other, the changes in Polish law have alleviated the requirements for prescribing these medicines. Therefore, it is important to achieve an acceptable balance between the restrictions imposed on opioids usage and their adequate clinical application.

UR - http://www.scopus.com/inward/record.url?scp=85045522780&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 545

EP - 548

JO - Acta Poloniae Pharmaceutica

JF - Acta Poloniae Pharmaceutica

SN - 0001-6837

IS - 2

ER -